| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Dividendenbekanntmachungen (20.03.2026) | 4.725 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADEMY SPORTS AND OUTDOORS INC US00402L1070 0,15 USD 0,1295 EUR ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0647 EUR AL SYDBANK... ► Artikel lesen | |
| 07:27 | Aktien KW 12 Iran Krieg und kein Ende? TACO fällt aus? Weltweite Rezession? News. Evotec. Ottobock. SFC Energy. All for One. Exasol. Softing. freenet. Mensch und Maschine. ThyssenKrupp nucera. HomeToGo. Aumann. Doc Morris. Fuchs. Krones. MAX Automation. U | 793 | Nebenwerte Magazin | Aktien: Wie letzte Woche - eine weitere Woche Bomben auf den Iran, keine erkennbaren "Erfolge" - ausser das sinnlos Menschen sterben. Und rekordhohe Ölpreise, Erdgas teurer als in der Ukraine-Preishochphase.... ► Artikel lesen | |
| Fr | Morning Market Movers: Super Micro Computer, Bimergen Energy, Palatin Technologies, Intellicheck See Big Swings | 609 | AFX News | HONG KONG (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Fr | Defence Therapeutics Inc.: Defence Therapeutics Announces Warrant Terms Amendment | 496 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 20, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular... ► Artikel lesen | |
| 07:02 | Megatrend Nanotechnologie - und NurExone Biologic im Zentrum der Entwicklung | Small- & Micro Cap Investment | |||
| Fr | Biogen Inc.: Results from Real-World, Long-Term Treatment Persistence with LEQEMBI (lecanemab-irmb) in the United States Presented at AD/PD 2026 | 368 | GlobeNewswire (Europe) | TOKYO and CAMBRIDGE, Mass., March 20, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts... ► Artikel lesen | |
| 10:10 | NurExone Biologic: ExoPTEN - realistische Perspektive zur Heilung von Nervenschäden | bullVestor | |||
| 08:24 | Omeros Corporation: Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment | 270 | Business Wire | Omeros Corporation (NASDAQ: OMER) today announced that it will host an industry session at the 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on March 22,... ► Artikel lesen | |
| Fr | QIAGEN N.V.: Qiagen Announces Form 20-F Annual Report Filing for 2025 Results | 253 | Business Wire | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended... ► Artikel lesen | |
| Fr | Biodesix, Inc.: Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis | 250 | GlobeNewswire (Europe) | LOUISVILLE, Colo., March 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical... ► Artikel lesen | |
| Fr | RedChip Companies, Inc.: Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 235 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / March 20, 2026 / RedChip Companies will air interviews with Off The Hook YS Inc. (NYSE American:OTH) and Enlivex Ltd. (NASDAQ:ENLV) on the RedChip Small Stocks, Big Money... ► Artikel lesen | |
| Fr | KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present New EKTERLY (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference | 218 | Business Wire | New interim data from the KONFIDENT-KID trial evaluating sebetralstat in children aged 2-11 accepted for late-breaking oral presentation KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced... ► Artikel lesen | |
| Fr | Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations | 168 | PR Newswire | SHANGHAI, March 20, 2026 /PRNewswire/ -- Henlius (2696.HK) today announced its 2025 annual results, marking its third consecutive year of profitability since 2023. During the reporting period... ► Artikel lesen | |
| 10:06 | Aelis Farma announces the successful start of the recruitment of the Phase 2B clinical trial with AEF0217 for the treatment of behavioral and cognitive impairments of people with Down syndrome (Trisomy 21) | 153 | Business Wire | AEF0217 is a first-in-class Signalling Specific inhibitor of the CB1 receptor (CB1-SSi) developed as a treatment for impairments in adaptive behaviours and cognition in neurodevelopmental disorders... ► Artikel lesen | |
| Fr | Antengene Corporation Limited: Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability | 62 | PR Newswire | SHANGHAI and HONG KONG, March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| BB BIOTECH | 49,450 | 2,47 | +4,99 % | 2,25 | 23.03.2026 | |
| CSL | 83,44 | 2,61 | +3,13 % | 1,84 | 10.03.2026 | |
| BML | 22,000 | 0,66 | +3,00 % | 60,00 | 30.03.2026 | |
| AMGEN | 298,60 | 8,41 | +2,82 % | 2,52 | 15.05.2026 | |
| KAMADA | 8,490 | 0,22 | +2,59 % | 0,78 | 23.03.2026 | |
| NOVONESIS | 46,340 | 0,87 | +1,88 % | 4,25 | 20.03.2026 | |
| GENUS | 29,800 | 0,38 | +1,28 % | 0,11 | 05.03.2026 | |
| STRYKER | 291,40 | 2,99 | +1,03 % | 0,88 | 31.03.2026 | |
| BIOMERIEUX | 91,35 | 0,90 | +0,99 % | 0,98 | 09.06.2026 | |
| BIO-TECHNE | 44,200 | 0,27 | +0,61 % | 0,08 | 13.02.2026 |